Pereiti į pagrindinį turinį
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • Apie mus 

      • Novartis Lietuvoje 
      • Strategija 
      • Įvairovė ir įtrauktis 
      • Žmonės ir kultūra 
      • Produktai 
      • Susisiekite su mumis 
      Apie mus
      Apie mus
    • Pacientai ir slaugytojai 

      • Novartis įsipareigojimas pacientams ir slaugytojams 
      • Ligos 
      • Produktai 
      • Pranešti apie nepageidaujamą reiškinį 

        • Pranešti apie įtariamą nepageidaujamą reiškinį 
      • Parama pacientų organizacijoms 
      Pacientai ir slaugytojai
    • Sveikatos priežiūros specialistai 

      • Novartis interneto svetainė sveikatos priežiūros specialistams 
      • Produktai 
      • Novartis vystomų produktų asortimentas 
      • Pranešti apie nepageidaujamą reiškinį 
      • Bendradarbiavimas su sveikatos priežiūros specialistais 
      • Novartis klinikiniai tyrimai 
      Gydytojai kalbasi ligonineje
      Sveikatos priežiūros specialistai
    • Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV) 

      • Etika, rizikos valdymas ir atitiktis 
      • Prieinamumas 
      • Aplinkos tvarumas 
      • Pasaulinė sveikatos apsauga 
      • Etiškas elgesys 

        • Etikos kodeksas 
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
      Aplinkos apsauga, socialinė atsakomybė ir valdysena (ASV)
    • Naujienos 

      • Naujienų archyvas  (link is external)
      • Susisiekite su mumis 
      A photo of people in a meeting hall
      Naujienos
    • Karjera 

      • Karjeros paieška 
      • Mūsų komandos 
      • Asmeninis augimas 
      • Jaunieji talentai 
      • Kaip mes dirbame 
      • Darbuotojų gerovė 
      • Įvairovė ir įtrauktis 
      • Apdovanojimai ir pripažinimas 
      Karjera
      Karjera
    • Koronavirusas 

      Koronavirusas
      Koronavirusas
    Lietuvos ofisas
    Pagrindinis puslapis
  1. Pagrindinis puslapis
  2. Karjeros paieška
  3. Karjeros paieška
  • Sort by Sort ascending
  • Darbo pavadinimas Sort ascending
  • Svetainė
  • Vieta
  • Padalinys
  • Veikla
  • Functional Area
  • Paskelbimo data
Darbo pavadinimas Sort ascending Svetainė Vieta Padalinys Veikla Functional Area Paskelbimo data
MR Intern Chengdu (Sichuan Province) China International Universal Hierarchy Node Others Geg 23, 2025
MR Intern Hangzhou (Zhejiang Province) China International Innovative Medicines Others Geg 23, 2025
MR Intern Hefei (Anhui Province) China International Innovative Medicines Others Geg 22, 2025
MR Intern Shanghai (Shanghai) China International Innovative Medicines Others Geg 22, 2025
MR Intern Wuhan (Hubei Province) China International Innovative Medicines Others Geg 22, 2025
MR Intern Nanjing (Jiangsu Province) China International Innovative Medicines Others Geg 20, 2025
MR Intern Tianjin (Tianjin) China International Innovative Medicines Others Geg 20, 2025
MR Intern Suzhou (Jiangsu Province) China International Innovative Medicines Others Geg 20, 2025
MR Intern Shanghai (Shanghai) China International Universal Hierarchy Node Others Geg 20, 2025
Pharmacy Intern Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Others Geg 19, 2025
Pharmacy Intern Hong Kong Hong Kong Special Administrative Region, China International Innovative Medicines Others Geg 19, 2025
MR Intern Suzhou (Jiangsu Province) China International Innovative Medicines Others Geg 19, 2025
PRODUCT MANAGER (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Others Geg 16, 2025
Postdoc Bioprocess Modelling & New Technologies Basel (City) Switzerland Development Universal Hierarchy Node Others Geg 15, 2025
Postgraduate GCS Ops Clinical Packaging Basel (City) Switzerland Development Innovative Medicines Others Geg 15, 2025
Legal Trainee – Research & Development and Innovative Medicines Basel (City) Switzerland Legal Pharma Research Others Geg 14, 2025
Postdoc Drug Product Development Data/Computational Scientist Oligonucleotide Platform Basel (City) Switzerland Development Innovative Medicines Others Geg 14, 2025
Legal Trainee – Novartis Corporate Functions Basel (City) Switzerland Legal Corporate Others Geg 12, 2025
MR Intern Changsha (Hunan Province) China International Innovative Medicines Others Geg 12, 2025
Post Doc RNA Delivery Basel (City) Switzerland Development Innovative Medicines Others Geg 08, 2025
MR Intern Changsha (Hunan Province) China International Innovative Medicines Others Geg 08, 2025
RA Postgraduate Intern in CH Basel (City) Switzerland Development Universal Hierarchy Node Others Geg 06, 2025
MR Intern Nanjing (Jiangsu Province) China International Innovative Medicines Others Geg 06, 2025
Lehrling Chemieverfahrenstechnik Schaftenau Austria Operations Innovative Medicines Others Geg 05, 2025
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Geg 05, 2025
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Geg 05, 2025
Lehrling Elektrotechnik Schaftenau Austria Operations Innovative Medicines Others Geg 05, 2025
MEDICAL LEAD (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Bal 30, 2025
Medical Lead Neurosciences (H/F) en stage Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Others Bal 30, 2025
Expert dveloppement des compétences (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France Pharma Innovative Medicines Others Bal 29, 2025
MR Intern Guangzhou (Guangdong Province) China International Innovative Medicines Others Bal 29, 2025
Chef de Projet Omnicanal (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Bal 25, 2025
Solutions digitales & développement d'automatisations (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Bal 25, 2025
Chef de produit hématologie (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Universal Hierarchy Node Others Bal 23, 2025
MR intern Guangzhou (Guangdong Province) China International Innovative Medicines Others Bal 23, 2025
MR Intern Xi an (Shaanxi Province) China International Innovative Medicines Others Bal 23, 2025
MR Intern Fuzhou (Fujian Province) China International Innovative Medicines Others Bal 23, 2025
MR Intern Suzhou (Jiangsu Province) China International Innovative Medicines Others Bal 21, 2025
MR Intern Xiangtan (Hunan Province) China International Innovative Medicines Others Bal 21, 2025
Legal Intern İstanbul Kavacık Türkiye Legal Innovative Medicines Others Bal 14, 2025
MR Intern Beijing (Beijing) China International Innovative Medicines Others Bal 14, 2025
MR Intern Chengdu (Sichuan Province) China International Innovative Medicines Others Bal 10, 2025
MR Intern Xi an (Shaanxi Province) China International Innovative Medicines Others Bal 10, 2025
MR Intern Shanghai (Shanghai) China International Innovative Medicines Others Bal 10, 2025
MR Intern Huanggang (Hubei Province) China International Innovative Medicines Others Bal 10, 2025
Chargé d'affaires Publiques (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Bal 09, 2025
MR Intern Qingdao (Shandong Province) China International Innovative Medicines Others Bal 09, 2025
Medical Lead Neurosciences (H/F) en alternance Paris Headquarter (Novartis Pharma S.A.S.) France Development Universal Hierarchy Node Others Bal 08, 2025
MR Intern Haikou (Hainan Province) China International Innovative Medicines Others Kov 31, 2025
MR Intern Huaian (Jiangsu Province) China International Innovative Medicines Others Kov 31, 2025

Pagination

  • ‹ Ankstesnis puslapis
  • 1
  • 2
  • › Next page

Novartis Lietuvoje

Naršyti Novartis svetainėje
  • Pacientai ir slaugytojai
  • Sveikatos priežiūros specialistai
  • Kompanijos etika
  • Naujienos
  • Karjera
Naujienos
  • Naujienų archyvas(link is external)
Mūsų portfelis
  • Novartis vystomų produktų asortimentas
  • Novartis produktai
Kitos Novartis svetainės
  • Pasaulinė svetainė(link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Privatumo politika
  • Naudojimo sąlygos
  • Slapukai
  • Slapukų nustatymai
  • Svetainės schema
  • Svetainės prieinamumas(link is external)
Novartis svetainių katalogas (link is external)
Ši svetainė skirta Lietuvos gyventojams